[HTML][HTML] Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models
C Ceci, MG Atzori, PM Lacal, G Graziani - International journal of …, 2020 - mdpi.com
The vascular endothelial growth factor (VEGF) family members, VEGF-A, placenta growth
factor (PlGF), and to a lesser extent VEGF-B, play an essential role in tumor-associated …
factor (PlGF), and to a lesser extent VEGF-B, play an essential role in tumor-associated …
[HTML][HTML] Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted/banned asbestos use
N Alpert, M van Gerwen, E Taioli - Translational lung cancer …, 2020 - ncbi.nlm.nih.gov
Research has established a strong association between asbestos exposure and malignant
mesothelioma, a deadly form of cancer. Since the early 1980's many countries have …
mesothelioma, a deadly form of cancer. Since the early 1980's many countries have …
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non …
A Scherpereel, J Mazieres, L Greillier… - The Lancet …, 2019 - thelancet.com
Background There is no recommended therapy for malignant pleural mesothelioma that has
progressed after first-line pemetrexed and platinum-based chemotherapy. Disease control …
progressed after first-line pemetrexed and platinum-based chemotherapy. Disease control …
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
PS Adusumilli, L Cherkassky… - Science translational …, 2014 - science.org
Translating the recent success of chimeric antigen receptor (CAR) T cell therapy for
hematological malignancies to solid tumors will necessitate overcoming several obstacles …
hematological malignancies to solid tumors will necessitate overcoming several obstacles …
Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma
V Panou, M Gadiraju, A Wolin, CM Weipert… - Journal of Clinical …, 2018 - ascopubs.org
Purpose The aim of the current study was to determine the prevalence and clinical
predictors of germline cancer susceptibility mutations in patients with malignant …
predictors of germline cancer susceptibility mutations in patients with malignant …
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A Scherpereel, P Astoul, P Baas… - European …, 2010 - Eur Respiratory Soc
Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …
[PDF][PDF] Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
V Delgermaa, K Takahashi, EK Park… - Bulletin of the World …, 2011 - SciELO Public Health
OBJECTIVE: To carry out a descriptive analysis of mesothelioma deaths reported worldwide
between 1994 and 2008. METHODS: We extracted data on mesothelioma deaths reported …
between 1994 and 2008. METHODS: We extracted data on mesothelioma deaths reported …
Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR …
GL Ceresoli, JG Aerts, R Dziadziuszko… - The Lancet …, 2019 - thelancet.com
Summary Background Tumour Treating Fields (TTFields) are a regional, antimitotic
treatment for solid tumours, which is based on the delivery of low-intensity alternating …
treatment for solid tumours, which is based on the delivery of low-intensity alternating …
Nanotechnology in the diagnosis and treatment of lung cancer
AM Cryer, AJ Thorley - Pharmacology & therapeutics, 2019 - Elsevier
Lung cancer is an umbrella term for a subset of heterogeneous diseases that are collectively
responsible for the most cancer-related deaths worldwide. Despite the tremendous progress …
responsible for the most cancer-related deaths worldwide. Despite the tremendous progress …
Estimation of the global burden of mesothelioma deaths from incomplete national mortality data
CO Odgerel, K Takahashi, T Sorahan… - Occupational and …, 2017 - oem.bmj.com
Background Mesothelioma is increasingly recognised as a global health issue and the
assessment of its global burden is warranted. Objectives To descriptively analyse national …
assessment of its global burden is warranted. Objectives To descriptively analyse national …